IUPAC name
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
SMILES
N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
Compound class
Dopamine Agents; Antiparkinson Agents; Antidyskinetics; Nervous System; Anti-Parkinson Drugs; Dopaminergic Agents; Dopa and Dopa Derivatives; CYP2D6 Inducers; CYP2D6 Inducers (strong);
Therapeutic area
For the treatment of idiopathic Parkinson's disease (Paralysis Agitans), postencephalitic parkinsonism, symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication, and manganese intoxication.
Common name
Levodopa
IUPAC name
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
SMILES
N[C@@H](CC1=CC(O)=C(O)C=C1)C(O)=O
INCHI
InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1
FORMULA
C9H11NO4
Common name
Levodopa
IUPAC name
(2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid
Molecular weight
197.188
clogP
-0.066
clogS
-0.266
HBond Acceptor
4
HBond Donor
5
Total Polar Surface Area
103.78
Number of Rings
1
Rotatable Bond
3
